Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A.
about
Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy.Does Mineralocorticoid Receptor Antagonism Prevent Calcineurin Inhibitor-Induced Nephrotoxicity?The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial).
P2860
Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Safety of Eplerenone for Kidne ...... and Receiving Cyclosporine A.
@ast
Safety of Eplerenone for Kidne ...... and Receiving Cyclosporine A.
@en
type
label
Safety of Eplerenone for Kidne ...... and Receiving Cyclosporine A.
@ast
Safety of Eplerenone for Kidne ...... and Receiving Cyclosporine A.
@en
prefLabel
Safety of Eplerenone for Kidne ...... and Receiving Cyclosporine A.
@ast
Safety of Eplerenone for Kidne ...... and Receiving Cyclosporine A.
@en
P2093
P2860
P50
P1433
P1476
Safety of Eplerenone for Kidne ...... n and Receiving Cyclosporine A
@en
P2093
Coralie Barbe
Olivier Toupance
Philippe Rieu
Sylvie Lavaud
P2860
P304
P356
10.1371/JOURNAL.PONE.0153635
P407
P577
2016-04-18T00:00:00Z